Sector Alpha

Track where the smart money flows in Indian equities

DashboardWeekly UpdateSector Deep DivesUploadPipelinePE CyclesBrainAboutHow We Research

Data updated weekly. Not financial advice.

sectoralpha · stock story
Pharma - Animal →
Home›Stocks›NGL Fine Chem Ltd
NGLFINENGL Fine Chem LtdPharma - Animal
₹3,000+143.5% 1y

NGL Fine Chem Ltd (NGLFINE) — share price & stock analysis

Profits have been broadly flat for two years, the market has pre-paid for the next leg, leaving little room for error.

MIXED STORY, RICHLY PRICEDBeating NIFTY 500 for 31 weeks
MOMENTUMSTAGE 2 UPTRENDBEATING NIFTY 31W
MARGINS EXPANDINGWC STRETCHINGEXPENSIVE VS HISTORY
DEEP CYCLICALEXPANSION
₹1,856 Cr
Market cap
38.6×
P/E
15.7%
ROE
77th pctile
vs own 10-yr valuation
By Sector Alpha Research · machine-compiled from Screener.in data · Updated 1 July 2026 · Sources: Screener.in company page, NSE quote · Not investment advice
The 30-second answer

NGL Fine Chem Ltd (NGLFINE) trades at ₹3,000 as of 1 July 2026, up 144% over the past year — beating NIFTY 500 for 31 weeks. The machine reads this as mixed story, richly priced: profits have been broadly flat for two years, the market has pre-paid for the next leg, leaving little room for error. It trades at a P/E of 38.6× (the 77th percentile of its own range); the price is in Stage 2 — advancing, 22 weeks in; the business cycle reads DEEP CYCLICAL / EXPANSION. Fundamentals-momentum score: 76/100 (mostly improving).

Data as of 1 July 2026 · every number traces to its Screener source column · not investment advice.

Key numbers
Market cap
₹1,856 Cr
P/E
38.6×
ROE
15.7%
vs own 10-yr valuation
77th pctile
Book value / share
₹533
EPS (TTM)
₹77.9
10-yr median P/E
30.3×
Revenue (FY26)
₹501 Cr
Profit after tax (FY26)
₹48 Cr
Weinstein stage
Stage 2 (22 weeks)
Data as of
1 July 2026
MOMENTUM OF THE FUNDAMENTALS
76/100
MOSTLY IMPROVING
Levels: ROCE 17% — decent · debt moderate (0.33× equity) · margins near the bottom of their band
SalesUp 57% YoY — 4 straight growth quarters
MarginsOPM 6.7% → 14.3% in a year
ProfitUp 1,200% YoY
Cash generationOperating cash ₹36.0 Cr → ₹43.0 Cr
Balance sheetD/E 0.27× → 0.33×
Committed ownersPromoters + funds hold 72.8% (a year ago: 72.7%)
DEEP CYCLICAL
Trough
Recovery
Expansion
Peak

Profits swing violently in this business — margins swinging 22 points peak to trough. That is what “deep cyclical” means: the same company looks brilliant at the top of its cycle and broken at the bottom.net_profit

Where the clock stands now: earnings sit at 83% of their historical range, margins are near the bottom of their band, and the market pays the expensive end of its range (77th percentile). That reads as EXPANSION — the middle of the cycle with margins still near their own lows — if margins mean-revert upward there is fuel left; if they don’t, growth has to do all the work.net_profit

One tension to hold: profits are compounding while margins sit near the bottom of their own historical band. That cuts both ways — there is recovery left to collect if margins climb back, but it also means today’s growth is being earned on thin economics.

4 of the 6 things we track are currently moving the right way — nearly everything is pulling in the same direction.

Where the levels actually stand: ROCE 17% — decent; debt moderate (0.33× equity); margins near the bottom of their band. Momentum says which way things are moving; these say where they are.

Read this number for what it is: it measures the DIRECTION of change, not the quality of the business. A mediocre business getting better scores high here; a great one having a soft quarter scores low. Profit, sales and margins count double, and a quarter of the score comes from our earnings-recovery lens (is the profit cycle turning up off its trough?).

THE ONE CHART THAT MATTERS

The market has pre-paid for growth that hasn’t arrived yet

Since Mar 2016, the stock is up 1,183% while earnings per share grew 320%. The difference is re-rating — investors paying more for the same rupee of profit.pricettm_eps

That works until it doesn’t: from here, earnings have to do the lifting, because the multiple has already done its part.

Today’s P/E of 38.6× means the market is paying up — this is the expensive end of its own 10-year history (77th percentile).pe_ratio

Price, earnings per share, and the P/E the market pays₹ · ×valuation_history
01,0002,0003,00050.0100₹ price₹ EPS₹3,000EPS ₹78P/E ×25.050.0med 30×39×Mar 16Sep 19Mar 23Jul 26
Data: Price, EPS and valuation (sampled — full series in the embedded dataset)
PeriodPrice (₹)EPS (TTM) (₹)P/E (×)
Mar 16226––
Jun 16240––
Aug 16326––
Oct 16334––
Dec 1631523.7–
Mar 17383––
May 17389––
Jul 17427––
Oct 17338––
Dec 17411––
Feb 18387––
May 18477––
Jul 18335––
Sep 18501––
Nov 18455––
Feb 19454––
Apr 19449––
Jun 1952532.616.1
Sep 1948733.114.7
Nov 1947429.815.9
Jan 20455–15.2
Apr 20289–11.5
Jun 20385–15.4
Aug 2062020.530.2
Oct 20889–43.4
Jan 211,180–27.9
Mar 211,65069.023.9
May 211,803–26.1
Aug 213,489107.732.4
Oct 212,669107.624.8
Dec 212,548104.424.4
Mar 222,03692.122.1
May 221,93580.624.0
Jul 221,754–21.7
Sep 221,48150.629.3
Dec 221,67835.647.1
Feb 231,540–51.3
Apr 231,49530.049.8
Jul 231,99234.058.6
Sep 231,98546.942.3
Nov 231,97156.335.0
Feb 241,92056.334.1
Apr 242,19862.135.4
Jun 242,35966.835.3
Aug 242,15168.131.6
Nov 242,01867.130.1
Jan 251,680–25.1
Mar 251,114–21.1
Jun 251,05033.831.1
Aug 251,38533.841.0
Oct 251,48933.844.1
Jan 261,390–41.5
Feb 262,29356.840.4
Apr 262,274–40.0
Jun 263,06478.039.3
Jul 263,00077.938.5

Price is the weekly close (₹). EPS is trailing-twelve-month profit per share, anchored on Screener's own snapshots; between snapshots it is filled from price ÷ P/E (an exact identity), and any fill straying more than 18% from the neighbouring snapshots is dropped rather than shown. The lower panel is the P/E — what the market pays per rupee of profit; the dotted line is its long-run median (30.3×).

WHERE THE PRICE IS IN ITS CYCLE

An uptrend that has held for 22 weeks

STAGE 2 · ADVANCING · 22 WEEKS

Every stock cycles through the same four seasons — a flat base (stage 1), an advance (2), a top (3), a decline (4). Right now this one is in Stage 2: advancing, 22 weeks in, confirmed.stage

The price sits above its rising 200-day average (₹2,110 today) and its strength against the index is still improving — trends like this persist more often than they reverse, which is why the system rides them instead of guessing the top.dma_200

Beating NIFTY 500 for 31 weeks — relative strength is the market’s live opinion, and right now it is on this stock’s side.rs_mansfield

What would end it: two Friday closes in a row below the 200-day line. That is the house exit rule — mechanical, no debates.dma_200

Weekly price with its 200-day and 50-day averages — stages shaded₹weinstein_stages
S2S201,0002,0003,000Price200-DMAStage 2 began · Feb 26Feb 16Aug 19Mar 23Jul 26
Data: Weekly price, moving averages and stage (sampled — full series in the embedded dataset)
PeriodPrice (₹)200-DMA (₹)50-DMA (₹)Stage
Feb 161902132384
May 162212222372
Aug 163262422682
Nov 163282833292
Jan 173142963172
Apr 173933293752
Jul 174063573932
Oct 173383603524
Dec 174793784122
Mar 184103994132
Jun 183874164242
Sep 186514094314
Nov 184554434782
Feb 194354424423
May 194224454453
Aug 194894734962
Nov 195104865082
Jan 204554694554
Apr 203134223444
Jul 203633963624
Oct 207304836192
Dec 201,1087351,0632
Mar 211,6501,0301,4312
Jun 212,2151,3221,7462
Sep 212,8941,9942,8602
Nov 212,6842,3332,7752
Feb 222,1942,4422,5512
May 221,9352,2862,1234
Aug 221,6902,0591,7974
Oct 221,4481,8251,5124
Jan 231,5691,7301,5774
Apr 231,3401,5801,3634
Jul 231,9921,5891,6374
Sep 231,9611,7891,9992
Dec 231,9591,8501,9572
Mar 242,0301,9262,0262
Jun 242,2982,0892,2842
Aug 242,1512,2402,4002
Nov 241,7902,1412,0134
Feb 251,1021,9561,6934
May 251,1281,6061,1784
Aug 251,3181,4191,2194
Oct 251,4891,4241,4304
Jan 261,4481,4101,3944
Apr 262,3291,7252,1122
Jun 263,0641,9902,4842
Jul 263,0002,1102,6992
THE LONG ARC

A lumpy ride — no clean trend in profits

Over 12 years, sales went from ₹79.0 Cr to ₹501 Cr (about 17% a year), and profit from ₹5.0 Cr to ₹48.0 Cr.revenuenet_profit

Revenue by year₹ Crannual_results
0200400FY14FY19FY24FY26
Data: Revenue by year
PeriodRevenue (₹ Cr)
FY1479
FY1588
FY1696
FY17100
FY18114
FY19153
FY20152
FY21258
FY22318
FY23278
FY24339
FY25368
FY26501
Profit by year₹ Crannual_results
020.040.060.0FY14FY19FY24FY26
Data: Profit by year
PeriodProfit after tax (₹ Cr)
FY145
FY158
FY1611
FY1715
FY1813
FY1920
FY208
FY2157
FY2250
FY2320
FY2441
FY2521
FY2648
OPM % by year%annual_results
10.020.030.0FY14FY19FY24FY26
Data: OPM % by year
PeriodOPM % (%)
FY1413.9
FY1517.0
FY1622.9
FY1725.0
FY1819.3
FY1920.9
FY2014.5
FY2131.0
FY2221.4
FY2312.6
FY2415.9
FY259.5
FY2614.6
CHAPTER 1 · THE ENGINE

Sales exploded 57% last quarter — the 4th straight quarter of growth

Revenue — the money that comes in from customers, before any costs.

Mar 26 sales were ₹149 Cr, up 57% on the same quarter last year.revenue

That makes 4 quarters of growth in a row — this is a trend, not a blip.revenue

Quarterly sales₹ Crquarterly_results
050.0100150YoY %+28+29+44+57Jun 23Jun 24Jun 25Mar 26
Data: Quarterly sales
PeriodRevenue (₹ Cr)YoY growth (%)
Jun 2371.0–
Sep 2380.0–
Dec 2388.0–
Mar 24100–
Jun 2491.028.2
Sep 2493.016.3
Dec 2489.01.1
Mar 2595.0-5.0
Jun 2510414.3
Sep 2512029.0
Dec 2512843.8
Mar 2614956.8
WATCH →If quarterly growth slips below 28%, the story weakens.
CHAPTER 2 · THE TAKE

Margins are widening — 7% → 14% in a year

Margins — the share of every ₹100 of sales kept as profit. Gross (after raw materials), operating (after running costs), net (after everything).

Of every ₹100 of sales, the company keeps ₹14.3 as operating profit (a year ago it kept ₹6.7).opm_pct

Zoom out and this is the page's quiet hero: annual operating margin bottomed at 9.5% in FY25 and has been rebuilt to 14.6% — that recovery, not sales alone, is what powers the profit growth elsewhere on this page.operating_profit

The gross margin moved the same way (50% → 52%), so this is about input costs and pricing power — the raw-material equation improved.gpm_pctopm_pct

Three margins, quarterly%margin_trends
0.020.040.0GrossOperatingNetJun 23Jun 24Jun 25Mar 26
Data: Three margins, quarterly
PeriodGross (%)Operating (%)Net (%)
Jun 2352.213.912.0
Sep 2354.917.413.1
Dec 2353.115.811.4
Mar 2452.615.912.4
Jun 2448.010.310.2
Sep 2452.812.410.5
Dec 2451.15.71.4
Mar 2549.76.70.6
Jun 2550.210.58.9
Sep 2552.414.38.0
Dec 2553.317.512.3
Mar 2652.514.49.0
WATCH →Two consecutive quarters of margin decline would break this trend.
CHAPTER 3 · THE BOTTOM LINE

Profit exploded 1,200% — mostly from keeping more of each sale

PAT (profit after tax) — what is left for shareholders after every cost, interest and tax.

Mar 26 profit after tax was ₹13.0 Cr, up 1,200% year on year.net_profit

Quarterly profit after tax₹ Crquarterly_results
0510.015.0YoY %−90−92+1,500+1,200Jun 23Jun 24Jun 25Mar 26
Data: Quarterly profit after tax
PeriodPAT (₹ Cr)YoY growth (%)
Jun 239.0–
Sep 2310.0–
Dec 2310.0–
Mar 2412.0–
Jun 249.00.0
Sep 2410.00.0
Dec 241.0-90.0
Mar 251.0-91.7
Jun 259.00.0
Sep 2510.00.0
Dec 2516.01,500.0
Mar 2613.01,200.0
Where the profit change came from (Mar 25 → Mar 26)₹ Cr
1+3+12+3−2−5+113PAT Mar 25More salesFattermarginsOther incomeDepreciationTaxEverythingelsePAT Mar 26

The single biggest driver was keeping more of each sale.

Data: Where the profit change came from (Mar 25 → Mar 26)
ComponentEffect (₹ Cr)
PAT Mar 251
More sales+3
Fatter margins+12
Other income+3
Depreciation−2
Tax−5
Everything else+1
PAT Mar 2613
CHAPTER 4 · THE ACID TEST

Most of the profit becomes cash — but not all

Operating cash flow (CFO) — the cash that actually arrived, vs PAT, the profit accounting reports. Annual figures.

Over the last 5 profitable years, the business reported ₹180 Cr of profit and collected ₹148 Cr of operating cash — about 82% conversion.operating_cash_flownet_profit

The gap sits in receivables: customers now take 95 days to pay, up from 81. Profit booked, cash pending.debtor_days

Cash collected vs profit reported (annual)₹ Crcash_flow
020.040.060.0Operating cash flowProfit after taxFY14FY19FY24FY26
Data: Cash collected vs profit reported (annual)
PeriodOperating cash flow (₹ Cr)Profit after tax (₹ Cr)
FY140.05.0
FY158.08.0
FY168.011.0
FY1710.015.0
FY1822.013.0
FY199.020.0
FY2020.08.0
FY2127.057.0
FY2214.050.0
FY2335.020.0
FY2420.041.0
FY2536.021.0
FY2643.048.0
CHAPTER 5 · THE PIPELINE

The cash cycle is stretching — more money stuck in the pipeline

Working capital — days of sales locked up in inventory and unpaid bills. Screener reports this yearly, so this chart is annual.

One rupee now takes about 104 days to go out the door as materials and come back as collected cash — up from 68 days the year before.cash_conversion_cycle

The biggest mover: suppliers being paid sooner (113 → 98 days).payable_days

Days of cash locked up (annual)daysratios
50100150Customers owe (debtor days)Stock on shelf (inventory days)We owe suppliers (payable days)FY14FY19FY24FY26
Data: Days of cash locked up (annual)
PeriodCustomers owe (debtor days) (days)Stock on shelf (inventory days) (days)We owe suppliers (payable days) (days)
FY1411077.0105
FY15107106150
FY1612390.0122
FY17110114139
FY1889.0134187
FY1979.010692.0
FY2063.0155116
FY2153.0132103
FY2274.013791.0
FY2386.069.063.0
FY2497.098.0112
FY2581.0101113
FY2695.010798.0
CHAPTER 6 · THE BUILD

Building hard — new capacity is under construction

Capex — money spent on plants, machines and buildings. Gross block is what exists; CWIP (capital work-in-progress) is what is being built. Annual.

The productive asset base has gone from ₹19.0 Cr (FY14) to ₹164 Cr, with another ₹95.0 Cr of capacity under construction right now.fixed_assetscwip

Work-in-progress is 58% of the existing asset base — that is a serious bet on future demand. Capacity like this shows up in sales with a lag; it is tomorrow’s growth being paid for today.cwip

The build is bigger than the cash engine: investing outflows (₹133 Cr) exceeded operating cash (₹99.0 Cr) over the last 3 years — the difference comes from debt or shareholders.investing_cash_flowoperating_cash_flow

Assets in place vs under construction (annual)₹ Crbalance_sheet
050.0100150Fixed assetsUnder construction (CWIP)FY14FY19FY24FY26
Data: Assets in place vs under construction (annual)
PeriodFixed assets (₹ Cr)Under construction (CWIP) (₹ Cr)
FY1419.00.0
FY1517.01.0
FY1624.02.0
FY1725.016.0
FY1856.03.0
FY1961.00.0
FY2068.00.0
FY2164.012.0
FY2289.06.0
FY2388.026.0
FY2486.046.0
FY2514350.0
FY2616495.0
WATCH →When CWIP converts to assets, sales must follow — two years of rising assets with flat sales would mean the bet is not paying.
CHAPTER 7 · SURVIVAL

Debt is present but comfortable

Debt-to-equity — borrowings against shareholders’ money. Computed from the balance sheet. Annual.

For every ₹100 shareholders have put in (and left in), the company has borrowed ₹33 — total borrowings have grown from ₹17.0 Cr to ₹108 Cr over the window.borrowings

Total borrowings (annual)₹ Crbalance_sheet
050.0100FY14FY19FY24FY26
Data: Total borrowings (annual)
PeriodBorrowings (₹ Cr)
FY1417.0
FY1513.0
FY1614.0
FY1723.0
FY1827.0
FY1927.0
FY2028.0
FY2116.0
FY2230.0
FY2332.0
FY2434.0
FY2577.0
FY26108
Debt vs shareholders’ money (annual)xbalance_sheet
00.250.50.75FY14FY19FY24FY26
Data: Debt vs shareholders’ money (annual)
PeriodDebt ÷ equity (x)
FY140.7
FY150.4
FY160.3
FY170.4
FY180.4
FY190.3
FY200.3
FY210.1
FY220.2
FY230.1
FY240.1
FY250.3
FY260.3
CHAPTER 8 · THE ENGINE ROOM

Every ₹100 kept in the business earns ₹17 — decent, not special

ROCE — profit earned per ₹100 of capital used. ROE — the same, per ₹100 of shareholders’ money alone. Annual.

Return on capital employed is 17.0% (a year ago: 9.0%). This is the single best test of business quality: what the company earns on the money it keeps.roce_pct

Rising returns on capital while growing is the rarest combination in investing — it means the new projects earn more than the old ones.roce_pct

Returns on capital (annual)%ratios
20.040.0ROCEFY14FY19FY24FY26
Data: Returns on capital (annual)
PeriodROCE (%)
FY1424.0
FY1529.0
FY1637.0
FY1734.0
FY1822.0
FY1928.0
FY2014.0
FY2154.0
FY2234.0
FY2312.0
FY2420.0
FY259.0
FY2617.0
CHAPTER 9 · WHO OWNS IT

The owners aren’t moving

Shareholding — who owns the company: founders (promoters), foreign funds (FII), domestic funds (DII).

Promoters hold 72.7%, essentially unchanged. Foreign funds own 0.0%, domestic funds 0.0%.promoters_pctfiis_pctdiis_pct

Who holds the shares, quarterly%shareholding
Promoters73.5% → 72.7% · down 0.8 pts
72.873.073.373.5Jun 23Jun 24Jun 25Mar 26
Foreign funds0.0% → 0.0% · flat
0.00.10.1Jun 23Jun 24Jun 25Mar 26
Domestic funds0.0% → 0.0% · flat
0.00.00.0Jun 23Jun 24Jun 25Mar 26
Data: Who holds the shares, quarterly
PeriodPromoters (%)Foreign funds (%)Domestic funds (%)
Jun 2373.50.00.0
Sep 2373.10.00.0
Dec 2373.10.00.0
Mar 2472.70.10.0
Jun 2472.70.00.0
Sep 2472.70.00.0
Dec 2472.70.10.0
Mar 2572.70.00.0
Jun 2572.70.00.0
Sep 2572.70.00.0
Dec 2572.70.00.0
Mar 2672.70.00.0
WHAT IS NOT HAPPENING
  • Promoters are not selling. Their stake has moved 0.1 points or less in 8 quarters — it sits at 72.7%.promoters_pct
  • Foreign funds have neither piled in nor fled — their stake has held near 0.0% for 8 quarters. No smart-money signal, in either direction.fiis_pct
THE VERDICT

Interesting, not obvious

The numbers are genuinely mixed, and the price already assumes the good news continues.

Best thing in the data: profit rising (₹1.0 Cr → ₹13.0 Cr).net_profit

Biggest worry: free cash flow falling (₹1.0 Cr → ₹−28.0 Cr).operating_cash_flow

The machine committee — 7 independent readsON WATCH · 49%
Earnings patternNEUTRAL0% · w21
Valuation cyclePOSITIVE52% · w19
CatalystsNEGATIVE58% · w14
Quality & safetyNEUTRAL42% · w14
TechnicalsPOSITIVE39% · w12
ValuationNEGATIVE60% · w10
Growth at a pricePOSITIVE62% · w10
Business quality7.0/10
Management5.0/10
7-model research readON WATCH · 49% confidence
WHAT WOULD CHANGE THIS VIEWTwo quarters of margins reversing would kill this story.

Machine-written research from Screener data — every number traces to its source column. Sector Alpha is not a SEBI-registered investment adviser; nothing here is a recommendation to buy or sell. Not investment advice.

More Pharma - Animal stocks
Viyash Scientific LtdHester Biosciences LtdAll Pharma - Animal stocks →
Frequently asked questions

Straight answers from the data

What does NGL Fine Chem Ltd do?

Incorporated in 1981, NGL Fine-Chem Ltd is a manufacturer and exporter of pharmaceuticals and intermediates for usage in veterinary and human health.[1]. It is listed in the Pharma - Animal sector with a market capitalisation of ₹1,856 Cr.

What is NGL Fine Chem Ltd's share price?

As of 1 July 2026, NGL Fine Chem Ltd trades at ₹3,000, up 144% over the past year, with a market capitalisation of ₹1,856 Cr. Beating NIFTY 500 for 31 weeks. Prices are weekly closes from Screener data; this page refreshes with each weekly update.

What is NGL Fine Chem Ltd's share price target?

Sector Alpha does not publish broker-style price targets. Our discounted-cash-flow model estimates NGL Fine Chem Ltd's intrinsic value at ₹2,981 per share under base assumptions (bear ₹984, bull ₹2,981), against the current price of ₹3,000 — a 0% premium to model value. The current price already implies roughly 23% annual earnings growth. These are model estimates, not forecasts — treat them as one input alongside the valuation history below, not as a target.

Is NGL Fine Chem Ltd stock overvalued or undervalued?

NGL Fine Chem Ltd trades at a P/E of 38.6× — the 77th percentile of its own 10.3-year trading range (median 30.3×), which is above the middle of its own historical range. The market has pre-paid for growth that hasn’t arrived yet. Since Mar 2016, the stock is up 1,183% while earnings per share grew 320%. The difference is re-rating — investors paying more for the same rupee of profit.

What did NGL Fine Chem Ltd report in its latest quarterly results?

In its most recent reported quarter (Q4 FY26, quarter ended March 2026): Mar 26 sales were ₹149 Cr, up 57% on the same quarter last year. Mar 26 profit after tax was ₹13.0 Cr, up 1,200% year on year. Figures are from Screener-scraped quarterly filings; the page updates when the next quarter is filed.

Is NGL Fine Chem Ltd growing?

Sales exploded 57% last quarter — the 4th straight quarter of growth. Mar 26 sales were ₹149 Cr, up 57% on the same quarter last year.

Are NGL Fine Chem Ltd's profits growing?

Profit exploded 1,200% — mostly from keeping more of each sale. Mar 26 profit after tax was ₹13.0 Cr, up 1,200% year on year.

What are NGL Fine Chem Ltd's operating margins?

Margins are widening — 7% → 14% in a year. In the most recent quarter, of every ₹100 of sales, the company keeps ₹14.3 as operating profit (a year ago it kept ₹6.7).

What is NGL Fine Chem Ltd's long-term growth record?

Revenue grew from ₹79 Cr in FY14 to ₹501 Cr in FY26 — a 16.6% compound annual growth rate over 12 years. Profit after tax compounded at 20.7% over the same period (₹5 Cr → ₹48 Cr).

Is NGL Fine Chem Ltd stock in an uptrend?

An uptrend that has held for 22 weeks. NGL Fine Chem Ltd is in Stage 2 — advancing, 22 weeks in (confirmed). Stages follow Stan Weinstein's four-phase read of weekly price against the 200-day average: basing (1), advancing (2), topping (3), declining (4).

Why is NGL Fine Chem Ltd stock rising?

The price is up 144% over the past year, in a confirmed Stage 2 uptrend (22 weeks), and has beaten NIFTY 500 for 31 weeks. Since 2016, the price is up 1,183% while earnings per share moved 320%.

Is NGL Fine Chem Ltd beating the NIFTY 500?

Yes — beating NIFTY 500 for 31 weeks, as of 1 July 2026. Relative strength is measured weekly against the NIFTY 500 (Mansfield RS): a positive reading means the stock has outperformed the index over the trailing window, week after week.

Where is NGL Fine Chem Ltd in its business cycle?

The data reads NGL Fine Chem Ltd as a deep cyclical business currently in its expansion phase — earnings at 83% of their own historical range, valuation at the 77th percentile. Profits swing violently in this business — margins swinging 22 points peak to trough. That is what “deep cyclical” means: the same company looks brilliant at the top of its cycle and broken at the bottom.

Who owns NGL Fine Chem Ltd — what is the promoter holding?

Promoters hold 72.7%, essentially unchanged. Foreign funds own 0.0%, domestic funds 0.0%. Shareholding is from Screener's quarterly filings data.

Does NGL Fine Chem Ltd have too much debt?

Debt is present but comfortable. For every ₹100 shareholders have put in (and left in), the company has borrowed ₹33 — total borrowings have grown from ₹17.0 Cr to ₹108 Cr over the window.

What is the bull case for NGL Fine Chem Ltd?

Profits have been broadly flat for two years, the market has pre-paid for the next leg, leaving little room for error. Best thing in the data: profit rising (₹1.0 Cr → ₹13.0 Cr). Sales exploded 57% last quarter — the 4th straight quarter of growth.

What is the bear case for NGL Fine Chem Ltd — what could break the story?

Biggest worry: free cash flow falling (₹1.0 Cr → ₹−28.0 Cr). Two quarters of margins reversing would kill this story. The nearest-term thing to watch: if quarterly growth slips below 28%, the story weakens. This falsification condition is stated up front so the thesis can be checked against incoming quarters, not defended after the fact.

Is NGL Fine Chem Ltd a stock worth studying right now?

Sector Alpha does not publish buy or sell recommendations — this is a research read, not advice. What the data says: interesting, not obvious. The numbers are genuinely mixed, and the price already assumes the good news continues. Across the 7-model scorecard the composite research signal is on watch at 49% confidence. This is machine-written research compiled from Screener data — every number traces to its source — and it is not investment advice. Do your own diligence.

Generated from Screener data · 12 sources · why_traces/1.0 + story/1.2
details
generated 2026-07-03 11:21 · 6 material moves detected
sources: screener_company_info, screener_quarterly_results, screener_annual_results, screener_valuation_history, screener_shareholding, screener_cash_flow, screener_ratios, screener_balance_sheet, screener_margin_trends, weinstein_stages, agent_scores, stock_timelines